The purpose of this trial is to evaluate if cebranopadol is safe and can decrease pain in patients when compared to placebo (a tablet that does not contain active product) and when compared to a marketed product containing pregabalin (Lyrica®, indicated for your pain condition). Furthermore, this trial will be undertaken to find out if the patient's general health and well-being improves under trial treatment.